Cancer Statistics, 2017 | Ca-A Cancer Journal for Clinicians | 2017 | 12K |
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel | Blood | 2017 | 2.8K |
Colorectal cancer statistics, 2017 | Ca-A Cancer Journal for Clinicians | 2017 | 2.6K |
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging | Ca-A Cancer Journal for Clinicians | 2017 | 1.8K |
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2017 | 1.1K |
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual | Ca-A Cancer Journal for Clinicians | 2017 | 1K |
Breast cancer statistics, 2017, racial disparity in mortality by state | Ca-A Cancer Journal for Clinicians | 2017 | 963 |
Enasidenib in mutant relapsed or refractory acute myeloid leukemia | Blood | 2017 | 831 |
Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual | Ca-A Cancer Journal for Clinicians | 2017 | 772 |
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2017 | 751 |
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study | Blood | 2017 | 653 |
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2017 | 627 |
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 | Annals of Oncology | 2017 | 586 |
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults | Blood | 2017 | 582 |
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab | Annals of Oncology | 2017 | 551 |
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy | Blood | 2017 | 522 |
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab | Annals of Oncology | 2017 | 468 |
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials | Annals of Oncology | 2017 | 454 |
Acute lymphoblastic leukemia: a comprehensive review and 2017 update | Blood Cancer Journal | 2017 | 436 |
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2017 | 426 |
Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual | Ca-A Cancer Journal for Clinicians | 2017 | 422 |
Tumor-associated macrophages: from basic research to clinical application | Journal of Hematology and Oncology | 2017 | 398 |
The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012 | Ca-A Cancer Journal for Clinicians | 2017 | 376 |
Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review | Annals of Oncology | 2017 | 372 |
Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly | Blood | 2017 | 365 |